[ET Net News Agency, 5 June 2025] BOCI raised the target price for Innovent Bio (01801)
to HKD82 from HKD56 and maintained the "buy" rating.
The research house said it estimates revenues at RMB11.4bn/14.2bn/17.9bn, respectively
for 2025E/26E/27E. (rc)